Endurance Wealth Management’s HOOKIPA Pharma HOOK Stock Holding History

Endurance Wealth Management’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$0	Hold	100	–	–	﹤0.01%	645
2023 Q1	$0	Hold	100	–	–	﹤0.01%	647
2022 Q4	$0	Hold	100	–	–	﹤0.01%	641
2022 Q3	$2K	Hold	100	–	–	﹤0.01%	562
2022 Q2	$2K	Hold	100	–	–	﹤0.01%	579
2022 Q1	$2K	Hold	100	–	–	﹤0.01%	607
2021 Q4	$2K	Hold	100	–	–	﹤0.01%	589
2021 Q3	$10K	Hold	100	–	–	﹤0.01%	523
2021 Q2	$7K	Hold	100	–	–	﹤0.01%	550
2021 Q1	$13K	Hold	100	–	–	﹤0.01%	503
2020 Q4	$11K	Hold	100	–	–	﹤0.01%	482
2020 Q3	$11K	Hold	100	–	–	﹤0.01%	457
2020 Q2	$11K	Buy	+100	New	+$9.75K	﹤0.01%	456

Other funds holding HOOK

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Endurance Wealth Management's HOOK Position: Q2 2023 in Review

Endurance Wealth Management held its HOOKIPA Pharma (HOOK) position steady in Q2 2023 at 100 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Endurance Wealth Management first reported a position in HOOK in Q2 2020 and has held it in 13 quarters since. The position peaked at $13K in Q1 2021. 53 funds tracked by Wall St. Rank hold HOOK as of Q2 2023.

Endurance Wealth Management held 100 shares of HOOKIPA Pharma worth $0 as of Q2 2023.
Endurance Wealth Management left its HOOKIPA Pharma share count unchanged in Q2 2023.
HOOKIPA Pharma made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #645 holding.
Endurance Wealth Management first reported a position in HOOKIPA Pharma in Q2 2020 and has held it in 13 quarters since.
Endurance Wealth Management's HOOKIPA Pharma position peaked at $13K in Q1 2021.
53 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.